Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

LM-AS-013 development for peripheral vascular disorders terminated

June 21, 1996

E. Merck reports fibrinogen (gpIIb/IIIa) antagonists

June 21, 1996

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Modified factor VII described for coagulation-related disorders

June 21, 1996

A02131-1: Novel PDE V inhibitor

June 14, 1996

Corvas reveals anticoagulant proteins

June 14, 1996

Thrombin/trypsin inhibitors from Oscillatoria agardhii

June 14, 1996

FDA allows initiation of clinical trials on Autologous Fibrinogen Delivery (AFD) kit

June 7, 1996

Genetics Institute readies factor IX marketing application

June 7, 1996

Cor Therapeutics' NDA for Integrilin faces FDA review

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...